What is the current annual EBITDA of NVS?

As of today, NVS annual EBITDA is $21.82B

What is 1-year change in NVS annual EBITDA?

NVS annual EBITDA is up +1.57% year-over-year

What is 3-year change in NVS annual EBITDA?

NVS annual EBITDA is up +27.58% over the past 3 years

How far is NVS annual EBITDA from its all-time high?

NVS annual EBITDA is currently at its all-time high

How does NVS annual EBITDA rank versus sector peers?

NVS annual EBITDA is higher than 99.47% of companies in Healthcare sector

When is NVS next annual earnings release?

The next annual earnings release for NVS is on February 3, 2027

What is the current quarterly EBITDA of NVS?

As of today, NVS quarterly EBITDA is $6.16B

What is NVS quarterly EBITDA most recent change?

NVS quarterly EBITDA was up +3.71% on September 30, 2026

What is 1-year change in NVS quarterly EBITDA?

NVS quarterly EBITDA is up +12.91% year-over-year

How far is NVS quarterly EBITDA from its all-time high?

NVS quarterly EBITDA is currently -5.52% below its historical high of $6.52B set on September 30, 2023

How does NVS quarterly EBITDA rank versus sector peers?

NVS quarterly EBITDA is higher than 99.42% of companies in Healthcare sector

When is NVS next earnings release?

The next earnings release for NVS is on February 3, 2027

What is the current TTM EBITDA of NVS?

As of today, NVS TTM EBITDA is $22.11B

What is NVS TTM EBITDA most recent change?

NVS TTM EBITDA was up +3.29% on September 30, 2026

What is 1-year change in NVS TTM EBITDA?

NVS TTM EBITDA is down -1.66% year-over-year

How far is NVS TTM EBITDA from its all-time high?

NVS TTM EBITDA is currently -4.14% below its historical high of $23.07B set on June 30, 2025

How does NVS TTM EBITDA rank versus sector peers?

NVS TTM EBITDA is higher than 99.42% of companies in Healthcare sector

When is NVS next earnings release?

The next earnings release for NVS is on February 3, 2027

Novartis AG (NVS) EBITDA History & Chart Since 1993

Annual EBITDA

$21.82B$337.33M+1.57%

December 31, 2025

Summary

Current Value: As of today, NVS annual EBITDA is $21.82B, up +1.57% on December 31, 2025
Historical Performance: NVS annual EBITDA is up +27.58% over the past 3 years, up +36.99% over the past 5 years
All-Time High Comparison: NVS annual EBITDA is currently at its all-time high
3-Year Low Comparison: NVS annual EBITDA is +27.58% above its 3-year low of $17.10B reached on an earlier date
Sector Comparison: NVS annual EBITDA is higher than 99.47% of companies in Healthcare sector

EBITDA Chart

beforeafter

Performance

NVS Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual EBITDA	Dec 31, 25	$21.82B	+1.6%	+27.6%	+37.0%	+85.6%
Quarterly EBITDA	Sep 30, 26	$6.16B	+12.9%	-5.5%	+30.6%	+51.4%
TTM EBITDA	Sep 30, 26	$22.11B	-1.7%	+5.2%	+25.5%	+41.2%
Price	Nov 6, 26	$162.55	+28.4%	+73.9%	+94.3%	+223.4%
PE Ratio	Nov 6, 26	31.04	+79.8%	+23.7%	+60.8%	+181.4%
Annual Revenue	Dec 31, 25	$54.81B	+9.0%	+29.6%	+12.0%	+9.2%
Annual EPS	Dec 31, 25	$7.19	+22.6%	+126.7%	+103.3%	+70.1%
Annual EBIT	Dec 31, 25	$16.47B	+6.8%	+58.6%	+52.2%	+77.5%
Annual Net Income	Dec 31, 25	$14.04B	+17.6%	+131.6%	+72.9%	+42.0%

EBITDA Highs

NVS Annual EBITDA Highs Comparison
Period	High	Date	Current
3Y	$21.82B	Dec 31, 25	at high
5Y	$21.82B	Dec 31, 25	at high
All	$21.82B	Dec 31, 25	at high

EBITDA Lows

NVS Annual EBITDA Lows Comparison
Period	Low	Date	Current
3Y	$17.10B	N/A	+27.6%
5Y	$15.93B	N/A	+37.0%
All	$4.15B	Dec 1, 93	+425.4%

EBITDA History

Year	Value	Change
2025	$21.82B	+1.6%
2024	$21.48B	+6.7%
2023	$20.14B	+17.8%
2022	$17.10B	+0.4%
2021	$17.03B	+6.9%
2020	$15.93B	+0.1%
2019	$15.92B	+13.0%
2018	$14.08B	-2.2%
2017	$14.40B	+5.2%
2016	$13.69B	-9.8%
2015	$15.18B	-11.1%
2014	$17.08B	+2.5%
2013	$16.65B	-0.8%
2012	$16.78B	+17.8%
2011	$14.25B	+21.2%
2010	$11.76B	+5.3%
2009	$11.16B	-8.0%

Year	Value	Change
2008	$12.13B	+25.1%
2007	$9.70B	+3.8%
2006	$9.34B	+14.2%
2005	$8.18B	+12.2%
2004	$7.30B	+2.5%
2003	$7.12B	+11.9%
2002	$6.36B	+19.0%
2001	$5.35B	-4.8%
2000	$5.62B	-6.4%
1999	$6.00B	-0.6%
1998	$6.03B	+8.4%
1997	$5.57B	-6.3%
1996	$5.94B	-4.8%
1995	$6.24B	+22.5%
1994	$5.10B	+22.7%
1993	$4.15B	-

FAQ

What is the current annual EBITDA of NVS?: As of today, NVS annual EBITDA is $21.82B
What is 1-year change in NVS annual EBITDA?: NVS annual EBITDA is up +1.57% year-over-year
What is 3-year change in NVS annual EBITDA?: NVS annual EBITDA is up +27.58% over the past 3 years
How far is NVS annual EBITDA from its all-time high?: NVS annual EBITDA is currently at its all-time high
How does NVS annual EBITDA rank versus sector peers?: NVS annual EBITDA is higher than 99.47% of companies in Healthcare sector
When is NVS next annual earnings release?: The next annual earnings release for NVS is on February 3, 2027

EBITDA Formula

EBITDA = Net Income + Interest Expense + Income Tax + D&A

Quarterly EBITDA

$6.16B$220.01M+3.71%

September 30, 2026

Summary

Current Value: As of today, NVS quarterly EBITDA is $6.16B, up +3.71% on September 30, 2026
Historical Performance: NVS quarterly EBITDA is up +12.91% year-over-year, down -5.52% over the past 3 years
All-Time High Comparison: NVS quarterly EBITDA is currently -5.52% below its historical high of $6.52B set on September 30, 2023
3-Year Low Comparison: NVS quarterly EBITDA is +41.23% above its 3-year low of $4.36B reached on December 31, 2023
Sector Comparison: NVS quarterly EBITDA is higher than 99.42% of companies in Healthcare sector

Performance

NVS Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly EBITDA	Sep 30, 26	$6.16B	+3.7%	+12.9%	-5.5%	+30.6%
Annual EBITDA	Dec 31, 25	$21.82B	–	+1.6%	+27.6%	+37.0%
TTM EBITDA	Sep 30, 26	$22.11B	+3.3%	-1.7%	+5.2%	+25.5%
Price	Nov 6, 26	$162.55	+5.4%	+28.4%	+73.9%	+94.3%
PE Ratio	Nov 6, 26	31.04	+33.5%	+79.8%	+23.7%	+60.8%
Quarterly Revenue	Sep 30, 26	$14.44B	+0.1%	+4.0%	+22.5%	+10.8%
Quarterly EPS	Sep 30, 26	$0.63	-63.3%	-69.0%	-26.1%	-48.7%
Quarterly EBIT	Sep 30, 26	$4.85B	+2.5%	+15.7%	+42.5%	+48.9%
Quarterly Net Income	Sep 30, 26	$1.19B	-63.5%	-69.7%	-21.4%	-56.9%

Quarterly EBITDA Highs

NVS Quarterly EBITDA Highs Comparison
Period	High	Date	Current
1Y	$6.16B	Sep 30, 26	at high
3Y	$6.52B	N/A	-5.5%
5Y	$6.52B	Sep 30, 23	-5.5%
All	$6.52B	Sep 30, 23	-5.5%

Quarterly EBITDA Lows

NVS Quarterly EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$4.95B	Mar 31, 26	+24.4%
3Y	$4.36B	Dec 31, 23	+41.2%
5Y	$4.04B	Sep 30, 22	+52.5%
All	-$10.99B	Dec 31, 00	+156.0%

Quarterly EBITDA History

Month	Value	Change
Sep 2026	$6.16B	+3.7%
Jun 2026	$5.94B	+19.9%
Mar 2026	$4.95B	-2.4%
Dec 2025	$5.07B	-7.0%
Sep 2025	$5.45B	-8.1%
Jun 2025	$5.93B	+3.5%
Mar 2025	$5.73B	+6.7%
Dec 2024	$5.37B	-11.0%
Sep 2024	$6.03B	+18.5%
Jun 2024	$5.09B	+3.0%
Mar 2024	$4.94B	+13.4%
Dec 2023	$4.36B	-33.1%
Sep 2023	$6.52B	+47.9%
Jun 2023	$4.40B	-6.0%
Mar 2023	$4.69B	-13.4%
Dec 2022	$5.41B	+34.0%
Sep 2022	$4.04B	-20.1%
Jun 2022	$5.06B	+16.2%
Mar 2022	$4.35B	-0.8%
Dec 2021	$4.39B	-6.9%
Sep 2021	$4.71B	+4.4%
Jun 2021	$4.52B	+1.5%
Mar 2021	$4.45B	+13.1%
Dec 2020	$3.93B	-16.3%
Sep 2020	$4.70B	+22.2%
Jun 2020	$3.85B	-13.7%
Mar 2020	$4.46B	+21.2%
Dec 2019	$3.68B	-10.9%
Sep 2019	$4.13B	+9.3%
Jun 2019	$3.77B	+1.2%
Mar 2019	$3.73B	+15.6%
Dec 2018	$3.23B	-11.0%
Sep 2018	$3.62B	+7.2%
Jun 2018	$3.38B	+4.1%
Mar 2018	$3.24B	-15.9%
Dec 2017	$3.86B	-1.9%
Sep 2017	$3.93B	+5.6%
Jun 2017	$3.72B	-2.4%
Mar 2017	$3.82B	+8.2%
Dec 2016	$3.53B	-8.6%
Sep 2016	$3.86B	+0.1%
Jun 2016	$3.86B	+6.5%
Mar 2016	$3.62B	+12.3%
Dec 2015	$3.22B	-15.2%
Sep 2015	$3.80B	-7.2%
Jun 2015	$4.10B	-1.4%
Mar 2015	$4.16B	+11.5%
Dec 2014	$3.73B	-12.8%
Sep 2014	$4.27B	-11.6%
Jun 2014	$4.83B	+15.4%
Mar 2014	$4.19B	+10.4%
Dec 2013	$3.79B	-5.9%
Sep 2013	$4.03B	-5.6%
Jun 2013	$4.27B	+14.5%

Month	Value	Change
Mar 2013	$3.73B	+10.9%
Dec 2012	$3.36B	-6.0%
Sep 2012	$3.58B	-2.4%
Jun 2012	$3.67B	+13.8%
Mar 2012	$3.22B	+52.7%
Dec 2011	$2.11B	-48.1%
Sep 2011	$4.07B	-0.5%
Jun 2011	$4.09B	-4.8%
Mar 2011	$4.29B	+33.3%
Dec 2010	$3.22B	-14.3%
Sep 2010	$3.76B	+19.3%
Jun 2010	$3.15B	-19.7%
Mar 2010	$3.92B	+4.3%
Dec 2009	$3.76B	+14.0%
Sep 2009	$3.30B	+12.1%
Jun 2009	$2.94B	+7.5%
Mar 2009	$2.74B	+20.6%
Dec 2008	$2.27B	-24.8%
Sep 2008	$3.02B	+1.9%
Jun 2008	$2.96B	+7.6%
Mar 2008	$2.75B	+127.6%
Dec 2007	$1.21B	-57.4%
Sep 2007	$2.84B	+13.2%
Jun 2007	$2.51B	-9.8%
Mar 2007	$2.78B	+41.5%
Dec 2006	$1.97B	-22.2%
Sep 2006	$2.53B	+5.2%
Jun 2006	$2.40B	-1.6%
Mar 2006	$2.44B	+30.0%
Dec 2005	$1.88B	-23.3%
Sep 2005	$2.45B	+18.2%
Jun 2005	$2.07B	+17.8%
Mar 2005	$1.76B	-4.0%
Dec 2004	$1.83B	-6.8%
Sep 2004	$1.97B	-6.7%
Jun 2004	$2.11B	+12.0%
Mar 2004	$1.88B	-4.5%
Dec 2003	$1.97B	+7.6%
Sep 2003	$1.83B	+0.3%
Jun 2003	$1.83B	+4.6%
Mar 2003	$1.75B	+11.4%
Dec 2002	$1.57B	+5.4%
Sep 2002	$1.49B	+3.1%
Jun 2002	$1.44B	-70.3%
Mar 2002	$4.86B	+152.3%
Dec 2001	-$9.29B	-266.6%
Sep 2001	$5.58B	+474.3%
Jun 2001	$971.00M	-78.1%
Mar 2001	$4.44B	+140.4%
Dec 2000	-$10.99B	-325.1%
Sep 2000	$4.88B	+388.1%
Jun 2000	$1.00B	-82.4%
Mar 2000	$5.70B	-

FAQ

What is the current quarterly EBITDA of NVS?: As of today, NVS quarterly EBITDA is $6.16B
What is NVS quarterly EBITDA most recent change?: NVS quarterly EBITDA was up +3.71% on September 30, 2026
What is 1-year change in NVS quarterly EBITDA?: NVS quarterly EBITDA is up +12.91% year-over-year
How far is NVS quarterly EBITDA from its all-time high?: NVS quarterly EBITDA is currently -5.52% below its historical high of $6.52B set on September 30, 2023
How does NVS quarterly EBITDA rank versus sector peers?: NVS quarterly EBITDA is higher than 99.42% of companies in Healthcare sector
When is NVS next earnings release?: The next earnings release for NVS is on February 3, 2027

EBITDA Formula

EBITDA = Net Income + Interest Expense + Income Tax + D&A

TTM EBITDA

$22.11B$704.05M+3.29%

September 30, 2026

Summary

Current Value: As of today, NVS TTM EBITDA is $22.11B, up +3.29% on September 30, 2026
Historical Performance: NVS TTM EBITDA is down -1.66% year-over-year, up +5.20% over the past 3 years
All-Time High Comparison: NVS TTM EBITDA is currently -4.14% below its historical high of $23.07B set on June 30, 2025
3-Year Low Comparison: NVS TTM EBITDA is +10.74% above its 3-year low of $19.97B reached on December 31, 2023
Sector Comparison: NVS TTM EBITDA is higher than 99.42% of companies in Healthcare sector

Performance

NVS Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM EBITDA	Sep 30, 26	$22.11B	+3.3%	-1.7%	+5.2%	+25.5%
Annual EBITDA	Dec 31, 25	$21.82B	–	+1.6%	+27.6%	+37.0%
Quarterly EBITDA	Sep 30, 26	$6.16B	+3.7%	+12.9%	-5.5%	+30.6%
Price	Nov 6, 26	$162.55	+5.4%	+28.4%	+73.9%	+94.3%
PE Ratio	Nov 6, 26	31.04	+33.5%	+79.8%	+23.7%	+60.8%
TTM Revenue	Sep 30, 26	$55.35B	+1.0%	+1.7%	+23.9%	+8.1%
TTM EPS	Sep 30, 26	$5.24	-21.0%	-28.6%	+40.6%	+20.9%
TTM EBIT	Sep 30, 26	$16.87B	+4.1%	-2.4%	+35.0%	+48.0%
TTM Net Income	Sep 30, 26	$10.02B	-21.4%	-30.5%	+38.0%	+2.1%

TTM EBITDA Highs

NVS TTM EBITDA Highs Comparison
Period	High	Date	Current
1Y	$22.49B	N/A	-1.7%
3Y	$23.07B	Jun 30, 25	-4.1%
5Y	$23.07B	Jun 30, 25	-4.1%
All	$23.07B	Jun 30, 25	-4.1%

TTM EBITDA Lows

NVS TTM EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$21.41B	Mar 31, 26	+3.3%
3Y	$19.97B	Dec 31, 23	+10.7%
5Y	$17.61B	N/A	+25.5%
All	-$1.50B	Sep 30, 02	+1573.2%

TTM EBITDA History

Month	Value	Change
Sep 2026	$22.11B	+3.3%
Jun 2026	$21.41B	+0.0%
Mar 2026	$21.41B	-3.5%
Dec 2025	$22.19B	-1.3%
Sep 2025	$22.49B	-2.5%
Jun 2025	$23.07B	+3.8%
Mar 2025	$22.23B	+3.7%
Dec 2024	$21.44B	+5.0%
Sep 2024	$20.42B	-2.3%
Jun 2024	$20.91B	+3.4%
Mar 2024	$20.22B	+1.3%
Dec 2023	$19.97B	-5.0%
Sep 2023	$21.02B	+13.4%
Jun 2023	$18.54B	-3.4%
Mar 2023	$19.19B	+1.8%
Dec 2022	$18.86B	+5.7%
Sep 2022	$17.83B	-3.7%
Jun 2022	$18.51B	+3.0%
Mar 2022	$17.97B	-0.5%
Dec 2021	$18.07B	+2.6%
Sep 2021	$17.61B	+0.1%
Jun 2021	$17.60B	+4.0%
Mar 2021	$16.93B	-0.0%
Dec 2020	$16.94B	+1.5%
Sep 2020	$16.68B	+3.6%
Jun 2020	$16.11B	+0.5%
Mar 2020	$16.03B	+4.8%
Dec 2019	$15.31B	+3.0%
Sep 2019	$14.85B	+3.5%
Jun 2019	$14.35B	+2.8%
Mar 2019	$13.96B	+3.6%
Dec 2018	$13.47B	-4.5%
Sep 2018	$14.10B	-2.1%
Jun 2018	$14.41B	-2.3%
Mar 2018	$14.75B	-3.7%
Dec 2017	$15.32B	+2.2%
Sep 2017	$14.99B	+0.5%
Jun 2017	$14.92B	-0.9%
Mar 2017	$15.05B	+1.3%
Dec 2016	$14.86B	+2.1%
Sep 2016	$14.56B	+0.4%
Jun 2016	$14.50B	-1.6%
Mar 2016	$14.74B	-3.5%
Dec 2015	$15.27B	-3.2%
Sep 2015	$15.78B	-2.9%
Jun 2015	$16.25B	-4.3%
Mar 2015	$16.99B	-0.2%
Dec 2014	$17.02B	-0.4%
Sep 2014	$17.09B	+1.4%
Jun 2014	$16.85B	+3.4%
Mar 2014	$16.28B	+2.9%
Dec 2013	$15.83B	+2.8%
Sep 2013	$15.40B	+3.0%
Jun 2013	$14.94B	+4.2%

Month	Value	Change
Mar 2013	$14.34B	+3.7%
Dec 2012	$13.83B	+10.0%
Sep 2012	$12.58B	-3.7%
Jun 2012	$13.06B	-3.1%
Mar 2012	$13.48B	-7.3%
Dec 2011	$14.55B	-7.1%
Sep 2011	$15.66B	+2.0%
Jun 2011	$15.35B	+6.5%
Mar 2011	$14.41B	+2.6%
Dec 2010	$14.05B	-3.7%
Sep 2010	$14.59B	+3.2%
Jun 2010	$14.13B	+1.5%
Mar 2010	$13.93B	+9.3%
Dec 2009	$12.74B	+13.3%
Sep 2009	$11.25B	+2.6%
Jun 2009	$10.96B	-0.2%
Mar 2009	$10.98B	-0.1%
Dec 2008	$10.99B	+10.7%
Sep 2008	$9.93B	+1.8%
Jun 2008	$9.76B	+4.8%
Mar 2008	$9.31B	-0.3%
Dec 2007	$9.34B	-7.5%
Sep 2007	$10.09B	+3.2%
Jun 2007	$9.78B	+1.1%
Mar 2007	$9.68B	+3.6%
Dec 2006	$9.34B	+0.9%
Sep 2006	$9.25B	+0.8%
Jun 2006	$9.18B	+3.7%
Mar 2006	$8.84B	+8.4%
Dec 2005	$8.16B	+0.5%
Sep 2005	$8.12B	+6.3%
Jun 2005	$7.64B	-0.5%
Mar 2005	$7.67B	-1.6%
Dec 2004	$7.80B	-1.7%
Sep 2004	$7.93B	+1.8%
Jun 2004	$7.80B	+3.8%
Mar 2004	$7.51B	+1.9%
Dec 2003	$7.37B	+5.8%
Sep 2003	$6.97B	+5.2%
Jun 2003	$6.62B	+6.1%
Mar 2003	$6.24B	-33.3%
Dec 2002	$9.35B	+723.1%
Sep 2002	-$1.50B	-158.0%
Jun 2002	$2.59B	+22.2%
Mar 2002	$2.12B	+24.6%
Dec 2001	$1.70B	>+9,900.0%
Sep 2001	$0.00	+100.0%
Jun 2001	-$695.00M	-4.4%
Mar 2001	-$666.00M	-212.7%
Dec 2000	$591.00M	-94.9%
Sep 2000	$11.58B	+72.9%
Jun 2000	$6.70B	+17.6%
Mar 2000	$5.70B	-

FAQ

What is the current TTM EBITDA of NVS?: As of today, NVS TTM EBITDA is $22.11B
What is NVS TTM EBITDA most recent change?: NVS TTM EBITDA was up +3.29% on September 30, 2026
What is 1-year change in NVS TTM EBITDA?: NVS TTM EBITDA is down -1.66% year-over-year
How far is NVS TTM EBITDA from its all-time high?: NVS TTM EBITDA is currently -4.14% below its historical high of $23.07B set on June 30, 2025
How does NVS TTM EBITDA rank versus sector peers?: NVS TTM EBITDA is higher than 99.42% of companies in Healthcare sector
When is NVS next earnings release?: The next earnings release for NVS is on February 3, 2027

EBITDA Formula

EBITDA = Net Income + Interest Expense + Income Tax + D&A

Data Sources & References

NVS Official Website www.novartis.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm
NVS Profile on Yahoo Finance finance.yahoo.com/quote/NVS
NVS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nvs